Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Dec. 31, 2018	Jun. 30, 2018
Current assets:
Cash	$ 42,321	$ 22,013
Prepaid expenses	1,608	7,474
Deposits and other receivables	1,000	1,000
Total current assets	44,929	30,487
Property and equipment, net (Note 3)	1,711	1,448
Total assets	46,640	31,935
Current liabilities:
Accounts payable and accrued expenses	643,707	719,633
Deferred compensation (Note 4)	698,766	421,641
Loan payable and accrued interest (Note 5)	9,160,313	9,028,983
Total current liabilities	10,535,186	10,201,657
Convertible notes payable - affiliates (Note 6)	3,588,130	3,525,216
Total liabilities	14,123,316	13,726,873
Deficit:
Common stock, no par value, 100,000,000 shares authorized, 27,121,371 and 25,939,892 shares issued, respectively; 26,417,062 and 25,235,583 shares outstanding, respectively
Additional paid-in capital	109,507,489	108,117,330
Subscription receivable - affiliates (Note 7)	(504,650)	(174,650)
Accumulated deficit	(123,130,161)	(121,691,956)
Total Bion’s stockholders’ deficit	(14,127,322)	(13,749,276)
Noncontrolling interest	50,646	54,338
Total deficit	(14,076,676)	(13,694,938)
Total liabilities and deficit	46,640	31,935
Series B Preferred Stock [Member]
Current liabilities:
Series B Redeemable Convertible Preferred stock, $0.01 par value, 50,000 shares authorized; 200 shares issued and outstanding, liquidation preference of $35,000 and $34,000, respectively (Note 7)	32,400	31,400
Series A Preferred Stock [Member]
Deficit:
Preferred stock
Series C Preferred Stock [Member]
Deficit:
Preferred stock